Biomarker Evaluation and Clinical Development
Most candidate biomarkers are never adopted into clinical practice. The likelihood that a biomarker with good predictive properties will be incorporated into urologic decision-making and will improve patient care can be enhanced by following established principles of biomarker...
Main Author: | Melissa Assel, Andrew Vickers |
---|---|
Format: | Article |
Language: | English |
Published: |
The Société Internationale d’Urologie (SIU)
2020-10-01
|
Series: | Société Internationale d’Urologie Journal |
Subjects: | |
Online Access: | https://siuj.org/index.php/siuj/article/view/43/6 |
Similar Items
-
Early-Stage Ovarian Malignancy Score versus Risk of Malignancy Indices: Accuracy and Clinical Utility for Preoperative Diagnosis of Women with Adnexal Masses
by: Phichayut Phinyo, et al.
Published: (2020-12-01) -
Evaluating the clinical utility of an easily applicable prediction model of suicide attempts, newly developed and validated with a general community sample of adults
by: Marcel Miché, et al.
Published: (2024-03-01) -
Biomarkers for Treatment Response in Advanced Prostate Cancer
by: Samia Asif, et al.
Published: (2021-11-01) -
The Biomarker Toolkit — an evidence-based guideline to predict cancer biomarker success and guide development
by: Katerina-Vanessa Savva, et al.
Published: (2023-10-01) -
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy
by: Ugo Giovanni Falagario, et al.
Published: (2021-03-01)